Thinq Pharmaceuticals Inc Natick, MA - 01760

Thinq Pharmaceuticals Inc is categorized under Noncommercial Research Organizations in Natick, MA and active since 2006.

Thinq Pharmaceuticals Inc was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 541720 by the NAICS.

If you are seeking more information, feel free to contact Mukund Chorghade at the company’s single location by writing to 14 Carlson Circle, Natick, Massachusetts MA 01760 or by phoning (508) 651-7809. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Thinq Pharmaceuticals Inc
Contact Person: Mukund Chorghade
Address: 14 Carlson Circle, Natick, Massachusetts 01760
Phone Number: (508) 651-7809
Annual Revenue (USD): $500.000 to $999.999
Founded: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Noncommercial Research Organizations
SIC Code: 8733
NAICS Code: 541720
Share This Business:

Thinq Pharmaceuticals Inc was started in 2006 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Mukund Chorghade for inquiries that concern Thinq Pharmaceuticals Inc by calling the company number (508) 651-7809, as your correspondence is most welcome. Additionally, the physical location of the single location of Thinq Pharmaceuticals Inc can be found at the coordinates 42.272527,-71.377358 as well as the street address 14 Carlson Circle in Natick, Massachusetts 01760.

For its online presence, you may visit Thinq Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.